Related Experiment Video

Updated: Jul 3, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.1K

Pneumonia in childhood bacterial meningitis-Experience from three continents

Tuula Pelkonen1,2,3, Irmeli Roine4, Manuel Leite Cruzeiro3

  • 1Pediatrics, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Tropical Medicine & International Health : TM & IH
|February 12, 2024
PubMed
Abstract

Insights

Concomitant pneumonia significantly worsens outcomes for children with bacterial meningitis, particularly in Angola. This severe presentation, especially in younger children, requires urgent recognition and management strategies.

Area of Science:

  • Pediatric infectious diseases
  • Clinical epidemiology
  • Respiratory medicine

Background:

  • The impact of pneumonia co-occurring with childhood bacterial meningitis on disease progression and outcomes remains unclear.
  • This study investigates the association between concomitant pneumonia and bacterial meningitis in children across diverse geographical settings.

Purpose of the Study:

  • To determine the prevalence and clinical significance of pneumonia in children diagnosed with bacterial meningitis.
  • To identify risk factors associated with concomitant pneumonia in pediatric bacterial meningitis.
  • To evaluate the influence of pneumonia on the severity and prognosis of bacterial meningitis.

Main Methods:

  • Secondary analysis of prospectively collected data from five bacterial meningitis clinical trials.
  • Inclusion of children aged 2 months to 15 years with confirmed bacterial meningitis and clinical or radiographic evidence of pneumonia.
  • Multivariate analyses to identify predisposing factors and assess the impact on disease severity and sequelae.

Main Results:

  • Pneumonia prevalence varied significantly by region: 0% in Finland, 8% in Latin America, and 46% in Angola.
  • In Latin America, risk factors included young age (<1 year), seizures, and severe anemia.
  • In Angola, risk factors included prolonged illness (>3 days) and non-meningococcal meningitis. Concomitant pneumonia was linked to increased disease severity and disabling sequelae.

Conclusions:

  • Bacterial meningitis with concurrent pneumonia represents a significant and previously under-recognized severe clinical entity, particularly prevalent in Angola.
  • The findings highlight the need for specific diagnostic and management strategies for this severe form of pediatric bacterial meningitis, especially in high-prevalence regions.
Keywords:
bacterial infectionbacterial meningitischildpneumonia

More Related Videos

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

2.5K
Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/4306:06

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43

Published on: September 11, 2020

1.7K

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
219
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
238
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
272
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
327
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
327
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
243